🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
562,02 USD
Máx. histórico
608,49
2 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,64%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-0,65%
Cierre anterior
565,72
Rango de hoy
559,41 – 569,45
Volumen hoy
454.934
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,22 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 5 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 07/03/2007 | 27,18 | 27,26 | 26,77 | 26,96 | -0,96% | 1,80% | 2.379.400 |
| 06/03/2007 | 27,23 | 27,48 | 27,18 | 27,22 | +0,02% | 1,08% | 1.288.600 |
| 05/03/2007 | 27,44 | 27,89 | 27,22 | 27,22 | -1,18% | 2,46% | 1.411.600 |
| 02/03/2007 | 27,61 | 28,26 | 27,46 | 27,54 | -0,65% | 2,90% | 1.726.200 |
| 01/03/2007 | 27,80 | 28,14 | 27,26 | 27,72 | -1,35% | 3,17% | 1.514.800 |
| 28/02/2007 | 28,70 | 29,03 | 28,03 | 28,10 | -2,06% | 3,48% | 1.669.000 |
| 27/02/2007 | 29,06 | 29,25 | 28,24 | 28,69 | -1,96% | 3,48% | 2.151.000 |
| 26/02/2007 | 27,45 | 29,78 | 27,43 | 29,27 | +1,30% | 8,56% | 6.617.600 |
| 23/02/2007 | 28,89 | 29,03 | 28,65 | 28,89 | -0,33% | 1,32% | 852.200 |
| 22/02/2007 | 29,06 | 29,75 | 28,82 | 28,99 | -0,17% | 3,18% | 2.225.200 |
| 21/02/2007 | 28,27 | 29,10 | 27,90 | 29,04 | +2,06% | 4,26% | 3.387.200 |
| 20/02/2007 | 27,33 | 28,73 | 26,60 | 28,45 | +12,43% | 7,78% | 9.380.600 |
| 16/02/2007 | 25,38 | 25,46 | 25,00 | 25,31 | -0,30% | 1,79% | 1.686.000 |
| 15/02/2007 | 25,58 | 25,78 | 25,23 | 25,38 | -0,63% | 2,17% | 1.744.000 |
| 14/02/2007 | 24,88 | 25,89 | 24,29 | 25,54 | +2,82% | 6,45% | 6.991.200 |
| 13/02/2007 | 24,19 | 24,95 | 24,03 | 24,84 | +3,69% | 3,78% | 2.335.200 |
| 12/02/2007 | 23,92 | 24,21 | 23,85 | 23,96 | +0,08% | 1,53% | 1.913.200 |
| 09/02/2007 | 24,46 | 24,55 | 23,84 | 23,94 | -0,48% | 2,92% | 3.980.200 |
| 08/02/2007 | 25,53 | 25,58 | 24,05 | 24,05 | -4,47% | 5,97% | 3.654.200 |
| 07/02/2007 | 25,43 | 25,61 | 25,09 | 25,18 | -0,91% | 2,05% | 1.464.800 |
| 06/02/2007 | 25,36 | 25,72 | 25,31 | 25,41 | +0,10% | 1,62% | 1.272.400 |
| 05/02/2007 | 26,17 | 26,35 | 25,36 | 25,38 | -3,44% | 3,78% | 2.070.800 |
| 02/02/2007 | 26,25 | 26,49 | 26,06 | 26,29 | +0,61% | 1,62% | 2.390.600 |
| 01/02/2007 | 26,77 | 26,77 | 25,93 | 26,13 | -2,52% | 3,16% | 5.471.600 |
| 31/01/2007 | 27,15 | 27,48 | 26,79 | 26,80 | -1,38% | 2,52% | 1.594.600 |
| 30/01/2007 | 26,38 | 27,61 | 26,13 | 27,18 | -3,36% | 5,61% | 4.215.000 |
| 29/01/2007 | 28,09 | 28,36 | 27,98 | 28,12 | -0,07% | 1,35% | 908.800 |
| 26/01/2007 | 28,67 | 28,79 | 28,03 | 28,14 | -1,85% | 2,63% | 1.118.600 |
| 25/01/2007 | 28,98 | 29,07 | 28,34 | 28,67 | -1,38% | 2,52% | 815.600 |
| 24/01/2007 | 29,75 | 29,75 | 28,67 | 29,07 | -1,67% | 3,61% | 1.018.200 |